[PHARMA] QoQ Cumulative Quarter Result on 31-Mar-2019 [#1]

Announcement Date
16-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Mar-2019 [#1]
Profit Trend
QoQ- -53.81%
YoY- 11.55%
Quarter Report
View:
Show?
Cumulative Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 2,820,530 2,104,847 1,387,998 786,108 2,384,956 1,788,312 1,200,652 76.44%
PBT -191,865 46,609 42,724 30,243 70,220 58,280 40,677 -
Tax 42,418 -17,323 -13,814 -10,595 -26,990 -19,620 -17,322 -
NP -149,447 29,286 28,910 19,648 43,230 38,660 23,355 -
-
NP to SH -149,219 29,379 28,898 19,617 42,468 38,031 22,980 -
-
Tax Rate - 37.17% 32.33% 35.03% 38.44% 33.67% 42.58% -
Total Cost 2,969,977 2,075,561 1,359,088 766,460 2,341,726 1,749,652 1,177,297 85.00%
-
Net Worth 336,573 516,387 518,564 528,825 509,862 522,618 519,642 -25.08%
Dividend
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Div 22,177 22,168 22,149 15,630 41,621 36,401 23,383 -3.45%
Div Payout % 0.00% 75.46% 76.65% 79.68% 98.01% 95.71% 101.76% -
Equity
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Net Worth 336,573 516,387 518,564 528,825 509,862 522,618 519,642 -25.08%
NOSH 261,229 261,229 261,229 260,505 260,505 260,505 259,821 0.35%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -5.30% 1.39% 2.08% 2.50% 1.81% 2.16% 1.95% -
ROE -44.33% 5.69% 5.57% 3.71% 8.33% 7.28% 4.42% -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 1,081.04 807.07 532.65 301.76 916.82 687.79 462.11 75.95%
EPS -57.19 11.26 11.09 7.53 16.33 14.63 8.84 -
DPS 8.50 8.50 8.50 6.00 16.00 14.00 9.00 -3.72%
NAPS 1.29 1.98 1.99 2.03 1.96 2.01 2.00 -25.28%
Adjusted Per Share Value based on latest NOSH - 260,505
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 195.70 146.04 96.30 54.54 165.48 124.08 83.31 76.43%
EPS -10.35 2.04 2.01 1.36 2.95 2.64 1.59 -
DPS 1.54 1.54 1.54 1.08 2.89 2.53 1.62 -3.31%
NAPS 0.2335 0.3583 0.3598 0.3669 0.3538 0.3626 0.3605 -25.07%
Price Multiplier on Financial Quarter End Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 -
Price 2.06 2.44 2.84 2.27 2.78 2.89 2.88 -
P/RPS 0.19 0.30 0.53 0.75 0.30 0.42 0.62 -54.44%
P/EPS -3.60 21.66 25.61 30.14 17.03 19.76 32.56 -
EY -27.76 4.62 3.90 3.32 5.87 5.06 3.07 -
DY 4.13 3.48 2.99 2.64 5.76 4.84 3.13 20.24%
P/NAPS 1.60 1.23 1.43 1.12 1.42 1.44 1.44 7.25%
Price Multiplier on Announcement Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 20/02/20 20/11/19 23/08/19 16/05/19 21/02/19 19/11/18 17/08/18 -
Price 2.04 2.21 2.66 2.36 2.76 3.09 3.11 -
P/RPS 0.19 0.27 0.50 0.78 0.30 0.45 0.67 -56.73%
P/EPS -3.57 19.62 23.99 31.34 16.91 21.13 35.16 -
EY -28.04 5.10 4.17 3.19 5.92 4.73 2.84 -
DY 4.17 3.85 3.20 2.54 5.80 4.53 2.89 27.60%
P/NAPS 1.58 1.12 1.34 1.16 1.41 1.54 1.56 0.85%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment